Summary

wall street rises as midterm election begins. amgen hits record high. the s&p; 500 opened higher by 10.22 points or 0.27% at 3817.02 while the nasdaq composite gained 47.01 points or 0.44% to 10611.53 at the opening bell.

The Economic Times

amgen reaches all-time high. stock up 30% ytd.

Seeking Alpha Symbol - AMGN

us stocks-wall st climbs over 1% as midterm election begins. amgen hits record high. United States stock indexes rose for the third straight session on tuesday as voting began in the crucial midterm election that will determine control of congress with in

Nasdaq Symbol - VTAQ

us stocks-wall st rises as midterm election begins. amgen hits record high. United States stock indexes rose for the third straight session on tuesday as voting began in the crucial midterm election that will determine control of congress with investors h

Nasdaq Symbol - AMGN

dow movers: hd amgn. in early trading on tuesday shares of amgen topped the list of the days best performing dow jones industrial average components trading up 4.6%. year to date amgen registers a 28.8% gain.

Nasdaq - Markets

nasdaq 100 movers: lcid amgn. in early trading on tuesday shares of amgen topped the list of the days best performing components of the nasdaq 100 index trading up 5.5%. year to date amgen registers a 30.0% gain.

Nasdaq - Markets

wall st rises as midterm election begins. amgen hits record high.

Investing.com - Stock Market News

amgen data supports long-term growth potential say analysts.

Investing.com - Stock Market News

amgens olpasiran reduced cholesterol levels in 95% of patients in mid-stage study. ) presented end-of-treatment data from its phase 2 ocean(a)-dose study of olpasiran (formerly amg 890) in adults with elevated lipoprotein levels and a history of atheros

Benzinga - large-cap

amgen : phase 2 data show olpasiran delivers significant reduction in lipoprotein(a) levels. (rttnews) - amgen (amgn) said that its phase 2 data for olpasiran continue to demonstrate a significant reduction in lipoprotein(a) and provide strong evidence su

Nasdaq Symbol - AMGN

amgen (amgn) beats on q3 earnings & sales tweaks 2022 view. amgen amgn reported third-quarter 2022 earnings of $4.70 per share which beat the zacks consensus estimate of $4.43 as well as our estimate of $4.37 per share. earnings rose 15% year ov

Nasdaq Symbol - ABBV

amgen reports q3 higher profit despite slight fall in topline growth. ) down 1% y/y due to 8% volume growth offset primarily by a 5% lower net selling price

Benzinga - guidance

amgen revises 2022 guidance as q3 results beat on top and bottom lines.

Seeking Alpha Symbol - AMGN

amgen beats on revenue and profit expectations.

Investing.com - Stock Market News

looking at amgens recent unusual options activity. someone with a lot of money to spend has taken a ish stance on ). and retail traders should know. we noticed this today when the big position showed up on publicly available options history that we trac

Benzinga - markets

amgen downgraded at barclays citing rally fueled by weight loss therapy.

Seeking Alpha Symbol - AMGN

sell biopharma stock amgen ahead of its obesity drug update barclays says. the bank said the biopharma company will have to surpass high expectations after its stock move this month.

CNBC - Investing

amgen astrazenecas severe asthma therapy tezspire launches in canada.

Seeking Alpha Symbol - AMGN

nasdaq 100 movers: bidu amgn. in early trading on tuesday shares of amgen topped the list of the days best performing components of the nasdaq 100 index trading up 5.2%. year to date amgen inc registers a 8.6% gain.

Nasdaq Symbol - CBTX

us stocks-wall st falls on worries of lower third-quarter corporate profit. amgen jumps. United States stocks fell on tuesday in the run-up to third-quarter results from companies as profit expectations drop amid rising interest rates and stubborn inflati

Nasdaq Symbol - AAPL

dow movers: aapl amgn. in early trading on wednesday shares of amgen topped the list of the days best performing dow jones industrial average components trading up 1.8%. year to date amgen registers a 2.2% gain.

Nasdaq Symbol - AAPL

amgen (amgn) dips more than broader markets: what you should know. in the latest trading session amgen (amgn) closed at $225.99 marking a -0.39% move from the previous day. this move lagged the s&p; 500s daily loss of 0.21%. elsewhere the dow los

Nasdaq Symbol - DNAA

$100 invested in this stock 15 years ago would be worth $400 today. amgen (nasdaq:) has outperformed the market over the past 15 years by 3.43% on an annualized basis producing an average annual return of 9.79%. currently amgen has a market capitalization

Benzinga - dividends

amgen becomes oversold. the dividendrank formula at dividend channel ranks a coverage universe of thousands of dividend stocks according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fun

Nasdaq - Markets

amgen drops to six-month low amid latest challenges to pipeline.

Seeking Alpha - AMGN

amgen inc. (amgn) management presents at morgan stanleys 2022 global healthcare conference (transcript).

Seeking Alpha - Latest Articles

amgen is looking interesting on the dip.

Seeking Alpha - AMGN

amgen lumakras/vectibix combo shows promise in phase 1 trial in colorectal cancer.

Seeking Alpha - AMGN

amgen announces positive result for phase 1b study of combination of vectibix lumakras. (rttnews) - amgen inc. (amgn) monday announced positive results for its phase 1b codebreak 101 trial and confirmed 30 percent objective response rate for its amgens ve

Nasdaq - AMGN

amgen (amgn) investor presentation - slideshow.

Seeking Alpha - AMGN